Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

David Marc Weinstock, M.D.

Co-Author

This page shows the publications co-authored by David Weinstock and Samuel Ng.
Connection Strength

1.794
  1. RhoA G17V is sufficient to induce autoimmunity and promotes T-cell lymphomagenesis in mice. Blood. 2018 08 30; 132(9):935-947.
    View in: PubMed
    Score: 0.802
  2. Genomic landscape of young ATLL patients identifies frequent targetable CD28 fusions. Blood. 2020 04 23; 135(17):1467-1471.
    View in: PubMed
    Score: 0.229
  3. Targetable vulnerabilities in T- and NK-cell lymphomas identified through preclinical models. Nat Commun. 2018 05 22; 9(1):2024.
    View in: PubMed
    Score: 0.201
  4. The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice. Cancer Cell. 2016 07 11; 30(1):183.
    View in: PubMed
    Score: 0.177
  5. The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice. Cancer Cell. 2016 04 11; 29(4):574-586.
    View in: PubMed
    Score: 0.173
  6. Activity of the Type II JAK2 Inhibitor CHZ868 in B Cell Acute Lymphoblastic Leukemia. Cancer Cell. 2015 Jul 13; 28(1):29-41.
    View in: PubMed
    Score: 0.165
  7. Functional proteogenomics reveals biomarkers and therapeutic targets in lymphomas. Proc Natl Acad Sci U S A. 2017 06 20; 114(25):6581-6586.
    View in: PubMed
    Score: 0.047
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.